Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion

Liver International : Official Journal of the International Association for the Study of the Liver
George K K Lau

Abstract

HBeAg seroconversion, in association with undetectable levels of hepatitis B virus DNA as determined by polymerase chain reaction, is an important goal in the treatment of patients with HBeAg-positive chronic hepatitis B (CHB). Achievement of sustained HBeAg seroconversion at an early age (<40 years) is associated with a reduced incidence of hepatic complications, increased rates of HBsAg loss and seroconversion and improved survival rates, whether the seroconversion is spontaneous or treatment induced. Patients with HBeAg-positive CHB who achieve sustained HBeAg seroconversion and complete 6-12 months of consolidation therapy are eligible for stopping therapy. In randomized clinical studies involving patients with HBeAg-positive CHB, treatment with pegylated interferon (PegIFN)-alpha is associated with higher and more durable HBeAg seroconversion rates than are lamivudine and adefovir. More recently, newer generation oral nucleos(t)ide analogs (NAs) have become available. These include entecavir, telbivudine and tenofovir, and they demonstrate superior antiviral potency and efficacy. This review examines the importance of HBeAg seroconversion as an end point for therapy in the treatment of patients with HBeAg-positive CHB, and...Continue Reading

References

Jan 1, 1995·Springer Seminars in Immunopathology·F V Chisari, C Ferrari
May 30, 1996·The New England Journal of Medicine·C NiederauD Häussinger
Nov 15, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G FattovichS W Schalm
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S M LinY F Liaw
Oct 21, 1999·The New England Journal of Medicine·J L DienstagN A Brown
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B C SongY S Lee
Dec 29, 2000·Journal of Hepatology·J H KaoD S Chen
May 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yao-Shih HsuYun-Fan Liaw
Jul 19, 2002·The New England Journal of Medicine·Hwai-I YangUNKNOWN Taiwan Community-Based Cancer Screening Project Group
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jules L DienstagEugene Schiff
Oct 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rong-Nan ChienYun-Fan Liaw
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Monika van ZonneveldHarry L A Janssen
Oct 9, 2004·Journal of Clinical Microbiology·Man-Fung YuenChing-Lung Lai
Jan 11, 2005·Lancet·Harry L A JanssenUNKNOWN Rotterdam Foundation for Liver Research
Mar 2, 2005·Nature Reviews. Immunology·Barbara Rehermann, Michelina Nascimbeni
Jul 1, 2005·The New England Journal of Medicine·George K K LauUNKNOWN Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
Jan 25, 2006·The American Journal of Medicine·Yasuji AraseHiromitsu Kumada
Mar 10, 2006·The New England Journal of Medicine·Ting-Tsung ChangUNKNOWN BEHoLD AI463022 Study Group
Apr 25, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Monika van ZonneveldUNKNOWN HBV 99-01 Study Group
Sep 7, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Chun-Jen LiuDing-Shinn Chen
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F Lok, Brian J McMahon
Apr 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chia-Ming Chu, Yun-Fan Liaw
Aug 8, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chee-Kin HuiUNKNOWN Hong Kong Liver Fibrosis Study Group
Aug 19, 2007·World Journal of Gastroenterology : WJG·Fen-Yu RenXi-Xu Piao
Oct 3, 2007·Annals of Internal Medicine·Henry L Y ChanUNKNOWN 018 Study Group
Nov 7, 2007·Gastroenterology·Robert G GishHelena Brett-Smith
Dec 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jinlin HouJidong Jia
Dec 21, 2007·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN Globe Study Group
Dec 22, 2007·Journal of Hepatology·Giovanna FattovichFrancesco Donato
Jan 29, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael W FriedMatei Popescu
Aug 13, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander EvansNikolai V Naoumov

❮ Previous
Next ❯

Citations

Sep 22, 2011·ClinicoEconomics and Outcomes Research : CEOR·Giorgio L ColomboSergio Di Matteo
May 10, 2011·Gastroenterología y hepatología·Javier Fuentes Olmo, Rafael Uribarrena Amézaga
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jing HeRon Goeree
May 30, 2017·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Marlone Cunha-SilvaJazon R S Almeida
Mar 3, 2012·European Journal of Gastroenterology & Hepatology·María ButiUNKNOWN ORIENTE Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of Viral Hepatitis
W Chotiyaputta, A S F Lok
Gastroenterology Clinics of North America
Maximilian Lee, Emmet B Keeffe
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Jules L DienstagEugene Schiff
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Anna S Lok, Brian J McMahon
The New England Journal of Medicine
Yun-Fan LiawCirrhosis Asian Lamivudine Multicentre Study Group
© 2021 Meta ULC. All rights reserved